The Jewish General Hospital Proteomics Centre encompasses the Segal Cancer Proteomics Centre (SCPC) and the Warren Y. Soper Program in Translational Proteomics. The SCPC applies state-of-the-art quantitative mass spectrometry-based proteomics and metabolomics methods for research, provides services to the academic, pharmaceutical and biotechnology groups, and translates quantitative mass spectrometry assays to the clinic.
• (Fundamental) method development
• MultiOMICS for personalized medicine
• Targeted MS assays for the clinic
| || |
• Identification of PTMs
• Relative quantitative proteomics and phosphoproteomics
• Targeted quantitative MS proteomics & metabolomics
• Protein-protein interactions
Our technologies can be applied to a wide range of samples, from purified proteins and protein complexes to biofluids, cells, biopsies and FFPE tissues, requiring only minimal sample amounts (e.g. few µL of blood; few µg of total protein from cells and tissues).